Viewing Study NCT00384150

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-02-04 @ 5:50 AM
Study NCT ID: NCT00384150
Status: TERMINATED
Last Update Posted: 2015-11-26
First Post: 2006-10-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)
Sponsor: Biogen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin's View
Keywords:

Keywords

Keyword Brief Keyword Text View
None galiximab View
None antibody View
None refractory View
None follicular View
None relapsed View
None NHL View
None rituximab View
None retreatment View